Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,020
Closed -$887K 3552
2025
Q2
$887K Buy
9,020
+2,626
+41% +$248K 0.02% 448
2025
Q1
$592K Buy
6,394
+5,225
+447% +$482K 0.01% 532
2024
Q4
$106K Sell
1,169
-3,249
-74% -$298K ﹤0.01% 1236
2024
Q3
$426K Buy
4,418
+728
+20% +$71K 0.01% 622
2024
Q2
$339K Buy
3,690
+827
+29% +$76.7K 0.01% 661
2024
Q1
$264K Buy
2,863
+2,528
+755% +$237K 0.01% 751
2023
Q4
$31.8K Buy
335
+98
+41% +$9.15K ﹤0.01% 1665
2023
Q3
$22.1K Sell
237
-13
-5% -$1.2K ﹤0.01% 1786
2023
Q2
$22.9K Buy
250
+42
+20% +$3.45K ﹤0.01% 1788
2023
Q1
$15.3K Buy
208
+11
+6% +$952 ﹤0.01% 1952
2022
Q4
$16.5K Sell
197
-2
-1% -$180 ﹤0.01% 1795
2022
Q3
$19K Sell
199
-16
-7% -$1.91K ﹤0.01% 1693
2022
Q2
$23K Sell
215
-27
-11% -$3.45K ﹤0.01% 1594
2022
Q1
$42K Sell
242
-44
-15% -$6.57K ﹤0.01% 1363
2021
Q4
$46K Buy
286
+39
+16% +$6.27K ﹤0.01% 1363
2021
Q3
$37K Buy
247
+68
+38% +$14.1K ﹤0.01% 1414
2021
Q2
$44K Sell
179
-26
-13% -$6.82K ﹤0.01% 1299
2021
Q1
$54K Buy
205
+10
+5% +$2.82K ﹤0.01% 1139
2020
Q4
$57K Buy
195
+17
+10% +$4.36K ﹤0.01% 1044
2020
Q3
$42K Sell
178
-14
-7% -$3.18K ﹤0.01% 1127
2020
Q2
$38K Hold
192
﹤0.01% 1145
2020
Q1
$35K Buy
192
+47
+32% +$8.36K ﹤0.01% 1059
2019
Q4
$24K Hold
145
﹤0.01% 1308
2019
Q3
$19K Buy
145
+13
+10% +$1.69K ﹤0.01% 1366
2019
Q2
$16K Hold
132
﹤0.01% 1376
2019
Q1
$16K Hold
132
﹤0.01% 1305
2018
Q4
$15K Hold
132
﹤0.01% 1164
2018
Q3
$16K Hold
132
﹤0.01% 1232
2018
Q2
$11K Hold
132
﹤0.01% 1293
2018
Q1
$8K Hold
132
﹤0.01% 1350
2017
Q4
$7K Hold
132
﹤0.01% 1413
2017
Q3
$7K Hold
132
﹤0.01% 1408
2017
Q2
$6K Hold
132
﹤0.01% 1486
2017
Q1
$8K Hold
132
﹤0.01% 1296
2016
Q4
$6K Buy
+132
New +$5.61K ﹤0.01% 1283

Other funds holding AMED

Parallel Advisors's AMED Position: Q3 2025 in Review

Parallel Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,020 shares — an estimated $887K sold.

Parallel Advisors first reported a position in AMED in Q4 2016 and held it in 35 quarters. The position peaked at $887K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Parallel Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Parallel Advisors sold 9,020 Amedisys shares in Q3 2025, an estimated $887K.
  • Parallel Advisors first reported a position in Amedisys in Q4 2016 and held it in 35 quarters.
  • Parallel Advisors's Amedisys position peaked at $887K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.